Russian registry of resistant arterial hypertension (“REGATTA”): study design.

I.E. Chazova, MD, PhD, Prof; V.V. Fomin, MD, PhD; M.A. Razuvaeva, MD; A.V. Vigdorchik, MD

Russian Cardiological Scientific Industrial Complex, I.M. Sechenov Moscow Medical Academy, “Novartis Pharma AG”

Design of Russian Registry of Resistant Arterial Hypertension Trial (“REGATTA”) is described. In the “REGATTA” trial clinical and epidemiological features of resistant and uncontrolled arterial hypertension will be characterized, as well as efficacy of fixed combination of amlodipine and valsartan.

Keywords

Similar Articles